ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Cardiac Rhythm Management
MAUDE LookupCardiac Rhythm ManagementQuadra Assura MP

Quadra Assura MP Adverse Events: FDA MAUDE Data

ABBOTT (ST. JUDE MEDICAL) · CRT-Defibrillator (CRT-D) · First cleared Apr 2018 · 8 device variants grouped

Total Reports

10,450

Reports (30d)

52

Active Signals

3

Open Recalls

2

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Remote Follow-Up Oversensing Observed

device technical, icd, observed device, remote follow, cardioverter

17

reports

2

Remote Oversensing Post-Paced T-Wave

net, remotely merlin, implantable cardioverter, exhibited post, merlin net

12

reports

3

Post-Paced T-Wave Oversensing

exhibited post, icd, defibrillator exhibited, wave oversensing, paced wave

11

reports

4

Inappropriate Shock Delivered by ICD

implantable cardioverter, icd, intervention, cardioverter defibrillator, defibrillator icd

10

reports

5

MRI Mode Not Engaged After Imaging

support contacted, resolve event, technical support, mri, mode

7

reports

6

Remote Transmission Revealed Oversensing

transmission revealed, remotely merlin, net review, merlin net, presented remotely

7

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghighDisproportionate reportinghighDisproportionate reportingmedium

Regulatory

FDA recalls for this device

Class II

Aug 16, 2023 · Open, Classified

Due to Bluetooth malfunction on a subset of Implantable Cardioverter Defibrillator (ICD) and Cardia Resynchronization Therapy Defibrillator *CRT-D) devices that were manufactured prior to April 2022 as a result of crystal component issue within the Bluetooth Low Energy (BLE) circuit. This results in the device entering an inductive telemetry only mode with loss of Bluetooth communication. In some instances, thought BLE communication is unavailable, the circuit may remain in a state which draws excessive power affecting battery longevity.

Class II

Mar 10, 2022 · Open, Classified

Due to a programmer software anomaly under very specific circumstance when executing a pacing capture Decrement Test in-clinic on implantable cardioverter and cardiac resynchronization therapy defibrillator devices, the programmer may continue to execute the Decrement Test instead of terminating the test and restoring the permanent programmed pacing parameters.

Evidence

Related research

Citations indexed from PubMed.

Keep exploring

Related devices in CRM

CAPSUREFIX Novus

MEDTRONIC, INC. · 43,528 reports

→

EMBLEM S-ICD

BOSTON SCIENTIFIC CORPORATION · 36,855 reports

→

Sprint Quattro Secure S MRI SureScan

MEDTRONIC, INC. · 36,335 reports

→

CapSureFix Novus MRI SureScan

MEDTRONIC, INC. · 27,017 reports

→

Durata

ABBOTT (ST. JUDE MEDICAL) · 19,619 reports

→

LINQ II

MEDTRONIC, INC. · 9,002 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 3 active signals detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.